ALKS
HEALTHYAlkermes plc.
CIK: 0001520262
Strong Sell
(70% confidence)
Last activity: 2 weeks ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Revenue $1.56B
Net Income $367.07M
Total Cash $272.96M
Total Debt $275.12M
Debt/Equity 0.19
Insider Roster (2 total, 2 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Cooke Shane DIRECTOR | 0 | 2 | -$2.12M | 103,744 shares $3.61M |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 0 | 6 | -$797K | 61,740 shares $2.11M |
Recent Transactions
SELL Cooke Shane (DIRECTOR)
32,113 shares @ $34.78
$1.12M
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Cooke Shane (DIRECTOR)
29,087 shares @ $34.34
$999K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
5,000 shares @ $34.24
$171K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
4,000 shares @ $33.54
$134K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
5,000 shares @ $30.00
$150K
Jan 8, 2026
Conviction: |
View SEC Filing →
SELL Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
4,000 shares @ $28.00
$112K
Jan 2, 2026
Conviction: |
View SEC Filing →
SELL Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
3,748 shares @ $30.00
$112K
Dec 3, 2025
Conviction: |
View SEC Filing →
SELL Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
4,000 shares @ $29.30
$117K
Dec 1, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.